The artificial oxygen carrier erythrocruorin—characteristics and potential significance in medicine
Date
2023Author
Kruczkowska, Weronika
Kciuk, Mateusz
Pasieka, Zbigniew
Kłosiński, Karol
Płuciennik, Elżbieta
Elmer, Jacob
Waszczykowska, Klaudia
Kołat, Damian
Kałuzińska-Kołat, Żaneta
Metadata
Show full item recordAbstract
The diminishing supply and increasing costs of donated blood have motivated research into novel hemoglobin-based oxygen carriers (HBOCs) that can serve as red blood cell (RBC) substitutes. HBOCs are versatile agents that can be used in the treatment of hemorrhagic shock. However, many of the RBC substitutes that are based on mammalian hemoglobins have presented key limitations such as instability and toxicity. In contrast, erythrocruorins (Ecs) are other types of HBOCs that may not suffer these disadvantages. Ecs are giant metalloproteins found in annelids, crustaceans, and some other invertebrates. Thus far, the Ecs of Lumbricus terrestris (LtEc) and Arenicola marina (AmEc) are the most thoroughly studied. Based on data from preclinical transfusion studies, it was found that these compounds not only efficiently transport oxygen and have anti-inflammatory properties, but also can be modified to further increase their effectiveness. This literature review focuses on the structure, properties, and application of Ecs, as well as their advantages over other HBOCs. Development of methods for both the stabilization and purification of erythrocruorin could confer to enhanced access to artificial blood resources.
Collections
The following license files are associated with this item: